The Combination Of Weak Expression Of PRDX4 And Very High MIB-1 Labelling Index Independently Predicts Shorter Disease-free Survival In Stage I Lung Adenocarcinoma.

Shioya, Akihiro; Guo, Xin; Motono, Nozomu; Mizuguchi, Seiya; Kurose, Nozomu; Nakada, Satoko; Aikawa, Akane; Ikeda, Yoshitaka; Uramoto, Hidetaka; Yamada, Sohsuke

Shioya, Akihiro; Guo, Xin; Motono, Nozomu; Mizuguchi, Seiya; Kurose, Nozomu; Nakada, Satoko; Aikawa, Akane; Ikeda, Yoshitaka; Uramoto, Hidetaka; Yamada, Sohsuke.

Afiliación

Shioya A; Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa.
Guo X; Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa.
Motono N; Department of Thoracic Surgery, Kanazawa Medical University, Ishikawa.
Mizuguchi S; Department of Pathology, Kanazawa Medical University Hospital, Ishikawa.
Kurose N; Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa.
Nakada S; Department of Pathology, Kanazawa Medical University Hospital, Ishikawa.
Aikawa A; Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa.
Ikeda Y; Department of Pathology, Kanazawa Medical University Hospital, Ishikawa.
Uramoto H; Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Ishikawa.
Yamada S; Department of Pathology, Kanazawa Medical University Hospital, Ishikawa.

Int J Med Sci ; 15(10): 1025-1034, 2018.

Article en En | MEDLINE | ID: mdl-30013444

Asunto(s)

Adenocarcinoma del Pulmón/genética; Adenocarcinoma/genética; Neoplasias Pulmonares/genética; Peroxirredoxinas/metabolismo; Adenocarcinoma/mortalidad; Adenocarcinoma/terapia; Adenocarcinoma del Pulmón/mortalidad; Adenocarcinoma del Pulmón/terapia; Adulto; Anciano; Anciano de 80 o más Años; Anticuerpos Antinucleares; Anticuerpos Monoclonales; Supervivencia sin Enfermedad; Femenino; Humanos; Japón; Neoplasias Pulmonares/mortalidad; Neoplasias Pulmonares/terapia; Masculino; Persona de Mediana Edad; Recurrencia Local de Neoplasia; Estrés Oxidativo; Pronóstico; Estudios Retrospectivos

Palabras clave

MIB-1; PRDX4; lung adenocarcinoma (LUAD); recurrence.; stage I

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Peroxirredoxinas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Int J Med Sci Asunto de la revista: MEDICINA Año: 2018 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google